Weber B Ankle Fractures With Associated Posterior Malleolus Fracture

Recruiting N/A Interventional Study
Posterior Malleolus Fractures Ankle Fractures Syndesmotic Injuries Patient Reported Outcome Measure Treatment Outcome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
198 (estimated)
Sponsor
Haukeland University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Ankle fractures constitute 9% of all fractures and have an incidence of approximately 187 per 100,000 persons per year in Norway. A posterior malleolar fragment (PMF), located on the lower backside of the tibia, is present in up to 46% of Weber B. Weber B fractures are the most common type of fractures of the fibula, located at the height of the syndesmosis. Patients with a PMF were recently shown…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Posterior malleolar (PM) fracture, of Mason \& Molly type 2A/2B, associated with Weber B lateral malleolar fracture, with or without medial malleolar fracture * Posterior malleoli \>=2 mm displaced (on CT in axial, sagital or coronal plane) * Patients informed, written consent…
Contacts

Jostein S Nilsen, MD

004792226426

jostein.skorpa.nilsen@helse-bergen.no

CONTACT

Kristian Pilskog, MD

+4798217343

kpilskog@gmail.com

CONTACT